Tom Helm
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Former Jets center Nick Mangold, a seven-time Pro Bowler, dies at 41 from complications of chronic kidney disease.
- Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Former Jets center Nick Mangold, a seven-time Pro Bowler, dies at 41 from complications of chronic kidney disease.
- Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Tom Helm
News from Tom Helm
